Rolf Ohlsson - Nanotechnology

Author Information

Rolf Ohlsson is a prominent researcher affiliated with the Department of Oncology-Pathology at Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden. His work primarily focuses on the intricate mechanisms of gene expression regulation, particularly in the context of cancer biology.

Research Contributions

Rolf Ohlsson has significantly contributed to the understanding of chromatin dynamics, gene expression regulation, and the role of non-coding RNA in these processes. His research often explores the implications of these molecular mechanisms in cancer cells, particularly focusing on the MYC oncogene and its regulation by WNT signaling and super-enhancers. His work also delves into the stochastic nature of chromatin networks and their impact on cellular fitness in cancer.

Aliases

The author is also known by several aliases, including R I Ohlsson, R Ohlsson, and R. Ohlsson. The most appropriate and complete name to use is Rolf Ohlsson.

Publication and Citation Metrics

Metric	Value
Citation Count	14,412
h-index	58
Paper Count	180

Publications:

Author Correction: WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating.

DOI: 10.1038/s41588-020-00715-9

Year: 2020

MYC as a driver of stochastic chromatin networks: implications for the fitness of cancer cells

DOI: 10.1093/nar/gkaa817

Year: 2020

Faculty Opinions recommendation of Highly rearranged chromosomes reveal uncoupling between genome topology and gene expression.

DOI: 10.3410/F.736194535.793563554

Year: 2019

WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating

DOI: 10.1038/s41588-019-0535-3

Year: 2019

Faculty of 1000 evaluation for Local regulation of gene expression by lncRNA promoters, transcription and splicing.

DOI: 10.3410/f.726886236.793546048

Year: 2018

Faculty of 1000 evaluation for The HoxD cluster is a dynamic and resilient TAD boundary controlling the segregation of antagonistic regulatory landscapes.

DOI: 10.3410/f.732345656.793546058

Year: 2018

Faculty of 1000 evaluation for Emerging Roles of Transcriptional Enhancers In Chromatin Looping And Promoter-Proximal Pausing Of RNA Polymerase II.

DOI: 10.3410/f.732199708.793546045

Year: 2018

F1000Prime recommendation of The interplay of epigenetic marks during stem cell differentiation and development.

DOI: 10.3410/f.728639958.793546046

Year: 2018

Faculty Opinions recommendation of Spatiotemporal allele organization by allele-specific CRISPR live-cell imaging (SNP-CLING).

DOI: 10.3410/F.732410816.793546062

Year: 2018

Faculty of 1000 evaluation for Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.

DOI: 10.3410/f.731254062.793546057

Year: 2018

What Are the Challenges in Nanotechnology Licensing?

How Can Researchers Avoid Honorary Authorship?

What is the Future of Smart Safety Goggles?

What are Nanotechnology Firewalls?

What Future Trends are Emerging in Cleanliness for Nanotechnology?

What are Nanotechnology Coatings?

What are FinFETs?

What Does it Mean to be a Fellow of AIMBE?

What are Nanoparticle Additives?

How Do Nano-Enabled Filters Work?

Partnered Content Networks

Relevant Topics